Olivier Colomban
7PUBLICATIONS
15CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Jul 07, 2025
Prognostic Value of a Joint K-PD Model With Tumor Size Dynamics and CA-125 Kinetics in Recurrent Ovarian Cancer Patients: BOLD Phase II GINECO Study.Aurore Carrot, Pauline Corbaux, Olivier Colomban
|Feb 16, 2024
Prognostic Value of the Modeled Prostate-Specific Antigen KELIM Confirmation in Metastatic Castration-Resistant Prostate Cancer Treated With Taxanes in FIRSTANA.Aurore Carrot, Stéphane Oudard, Olivier Colomban
|Jan 12, 2024
Confirmation of the utility of the CA-125 elimination rate (KELIM) as an indicator of the chemosensitivity in advanced-stage ovarian cancer in a "real-life setting".Lilian van Wagensveld, Olivier Colomban, Maaike A van der Aa
|Apr 19, 2023
Benefit From Fractionated Dose-Dense Chemotherapy in Patients With Poor Prognostic Ovarian Cancer: ICON-8 Trial.Olivier Colomban, Andrew Clamp, Adrian Cook
|Apr 01, 2022
Low probability of disease cure in advanced ovarian carcinomas before the PARP inhibitor era.Benoit You, Lilian Van Wagensveld, Michel Tod
|Mar 27, 2020
CA-125 ELIMination Rate Constant K (KELIM) Is a Marker of Chemosensitivity in Patients with Ovarian Cancer: Results from the Phase II CHIVA Trial.Benoit You, Patrick Robelin, Michel Tod
Pageof 2
Frequent Collaborators
6 joint publications
Benoit You
3 joint publications
Aurore Carrot
2 joint publications
Gilles Freyer
1 joint publications
Michel Fabbro
1 joint publications
Gwénael Ferron
1 joint publications
Alexandra Leary
1 joint publications
Hugo M Horlings
1 joint publications
Iain A McNeish
1 joint publications
Lilian van Wagensveld
1 joint publications
Maaike A van der Aa
